Why is Brawn Biotech falling/rising?

As of 15-Sep, Brawn Biotech Ltd is experiencing a price increase, currently at Rs 21.84, which reflects a rise of Rs 1.04 or 5.0%. The stock has shown strong performance today, outperforming its sector by 4.85% and has been on a consecutive gain streak for the last four days, accumulating a total return of 14.89% during this period. It opened with a gain of 5% and reached an intraday high of Rs 21.84. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend. Notably, there has been a significant increase in investor participation, with delivery volume rising by 385.24% compared to the 5-day average, suggesting heightened interest in the stock.
In the broader market context, Brawn Biotech's short-term performance has been impressive, with a 9.75% gain over the past week, significantly outpacing the Sensex, which only increased by 1.24% during the same period. Over the last month, the stock has risen by 21.27%, again outperforming the benchmark's 1.47% increase. However, while the stock has shown positive returns in the short term, its year-to-date performance of 2.49% lags behind the Sensex's 4.67% gain, and its long-term performance over three and five years shows a decline relative to the benchmark. This mixed performance highlights that while Brawn Biotech is currently rising, it has faced challenges in the longer term compared to broader market trends.